World
Merck Reports Strong 2024 Growth with €21.2 Billion in Sales, Projects Continued Expansion in 2025
Merck, a leading science and technology company, has delivered profitable growth in fiscal year 2024, demonstrating resilience and strategic execution acro...
March 07, 2025 | Company results
Frazier Life Sciences Launches Callio Therapeutics with $187M Series A to Advance Multi-Payload ADCs
Frazier Life Sciences launches Callio Therapeutics based on multi-payload antibody-drug conjugate technology and programs exclusively in-licensed from&nb...
March 05, 2025 | News
Elis Expands Cleanroom Solutions with Acquisition of BeMicron
Elis, the international multi-service provider for cleanroom, workwear, hygiene and facility services solutions, today announces the acquisition of 1...
March 05, 2025 | News
Elsevier Expands ClinicalKey AI with EHR and HIT Integrations to Enhance Clinician Workflows
Elsevier, a global leader in health information and data analytics, has announced further enhancements to ClinicalKey AI, the company's leading generative ...
March 04, 2025 | News
MasterControl Acquires Qualer to Integrate Asset Management into Life Sciences Quality and Manufacturing Platform
MasterControl, a leading provider of quality and manufacturing software solutions for life sciences, announced the acquisition of Qualer, a cloud-native as...
March 04, 2025 | News
SmithRx Expands Connect 360 Autoimmune Program Adding Stelara Biosimilars and Partnering with Costco Specialty Pharmacy
SmithRx, a transparent, 100% pass-through modern pharmacy benefits manager (PBM), announced a major expansion to its Connect 360 Autoimmune Program, ...
March 03, 2025 | News
Bambusa Therapeutics Initiates First Clinical Trial for BBT001 a Bispecific Antibody Targeting Atopic Dermatitis
Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopi...
March 03, 2025 | News
WuXi Biologics Passes Japan’s PMDA GMP Inspection for Wuxi Drug Substance Facilities
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced that it has...
February 28, 2025 | News
Metabolon Expands Multiomics Biomarker Discovery with New Integrated Bioinformatics Capabilities
Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic dev...
February 28, 2025 | News
Hong Kong Pharma Stocks Surge as AIM Vaccine Secures U.S. Clinical Approval for mRNA RSV Vaccine
The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively into the pharmaceutical...
February 27, 2025 | News
MicuRx’s MRX-4 and Contezolid Show Favorable Safety and Efficacy in Phase III Trial for Diabetic Foot Infections
Data Monitoring Committee (DMC) has completed the first safety and efficacy assessment of the global Phase III clinical trial, recommending continued pro...
February 26, 2025 | News
HBM Alpha Therapeutics Secures $395M Licensing Deal to Advance CRH-Targeting Therapy
HBM Alpha Therapeutics (HBMAT), Inc., an innovative biotechnology company incubated by Harbour BioMed (HKEX: 02142), announced a strategic collaborati...
February 26, 2025 | News
Thermo Fisher Scientific to Acquire Solventum’s Purification & Filtration Business for $4.1 Billion in Cash
Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that the company has en...
February 25, 2025 | News
Biological E. Partners with Bavarian Nordic to Manufacture Chikungunya Vaccine for LMICs in Asia, Africa, and Latin America
The manufacturing agreement is the first step in working together to provide Chikungunya Vaccine to low-and middle-income countries The initial t...
February 25, 2025 | News
Most Read
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
- China’s Biopharma Dealmaking Surges in H1 2025, Driven by Record Licensing and Oncology Focus
- Chikungunya in China: How a “Forgotten” Arbovirus Found the Perfect Storm
- How Innovation Gaps in Biopharma Raise New Safety Concerns
- Smart Implants and the Future of Musculoskeletal Injury Treatment
- How Ethical Gaps in Psychiatry Could Undermine Biopharma Progress
- The Evolving Landscape of Women’s Health Innovation in the Asia-Pacific
- Using NLP-Driven Decision Support in Emergency Health Assistance
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
